Population approaches in paediatricsCHATELUT, Etienne.Fundamental & clinical pharmacology. 2008, Vol 22, Num 6, pp 575-578, issn 0767-3981, 4 p.Conference Paper

The minimal impact of food on the pharmacokinetics of ridaforolimusSTROH, Mark; XIAODONG LI; MURPHY, Gail et al.Cancer chemotherapy and pharmacology. 2012, Vol 70, Num 1, pp 177-182, issn 0344-5704, 6 p.Article

Dose-dependency of pharmacokinetic/pharmacodynamic parameters after intravenous bolus doses of cisatracuriumCHEN, C; YAMAGUCHI, N; VARIN, F et al.British journal of anaesthesia. 2008, Vol 101, Num 6, pp 788-797, issn 0007-0912, 10 p.Article

Understanding the time course of pharmacological effect: a PKPD approachWRIGHT, Daniel F. B; WINTER, Helen R; DUFFULL, Stephen B et al.British journal of clinical pharmacology. 2011, Vol 71, Num 6, pp 815-823, issn 0306-5251, 9 p.Article

The influence of weightlessness on pharmacokineticsGANDIA, Peggy; SAIVIN, Sylvie; HOUIN, Georges et al.Fundamental & clinical pharmacology. 2005, Vol 19, Num 6, pp 625-636, issn 0767-3981, 12 p.Article

Population pharmacokinetics. III: Design, analysis, and application of population pharmacokinetic studiesETTE, Ene I; WILLIAMS, Paul J; LANE, James R et al.The Annals of pharmacotherapy. 2004, Vol 38, Num 12, pp 2136-2144, issn 1060-0280, 9 p.Article

Structural identifiability of physiologically based pharmacokinetic modelsYATES, James W. T.Journal of pharmacokinetics and pharmacodynamics (Print). 2006, Vol 33, Num 4, pp 421-439, issn 1567-567X, 19 p.Article

Population pharmacokinetic modeling : the importance of informative graphicsETTE, E. I; LUDDEN, T. M.Pharmaceutical research. 1995, Vol 12, Num 12, pp 1845-1855, issn 0724-8741Article

Metabolic Transformation of Sesamol and ex Vivo Effect on 2,2'-Azo-bis(2-amidinopropane)-dihydrochloride-lnduced HemolysisHOU, Yu-Chi; TSAI, Shang-Yuan; LIU, I-Ling et al.Journal of agricultural and food chemistry (Print). 2008, Vol 56, Num 20, pp 9636-9640, issn 0021-8561, 5 p.Article

Direct measurement of nitrous oxide kineticsDRUMMOND, G. B; FISHER, L; PUMPHREY, O et al.British journal of anaesthesia. 2012, Vol 109, Num 5, pp 776-781, issn 0007-0912, 6 p.Article

Drug Delivery Trends in Clinical Trials and Translational Medicine: Evaluation of Pharmacokinetic Properties in Special PopulationsCHIEN, Jenny Y; HO, Rodney J. Y.Journal of pharmaceutical sciences. 2011, Vol 100, Num 1, pp 53-58, issn 0022-3549, 6 p.Article

Pharmacokinetic and Pharmacodynamic Evaluation of the Lantibiotic MU1140GHOBRIAL, Oliver; DERENDORF, Hartmut; HILLMAN, Jeffrey D et al.Journal of pharmaceutical sciences. 2010, Vol 99, Num 5, pp 2521-2528, issn 0022-3549, 8 p.Article

Interspecies pharmacokinetics and in vitro metabolism of SQ109JIA, Lee; NOKER, Patricia E; COWARD, Lori et al.British journal of pharmacology. 2006, Vol 147, Num 5, pp 476-485, issn 0007-1188, 10 p.Article

Anticonvulsant activity, teratogenicity and pharmacokinetics of novel valproyltaurinamide derivatives in miceISOHERRANEN, Nina; YAGEN, Boris; SPIEGELSTEIN, Ofer et al.British journal of pharmacology. 2003, Vol 139, Num 4, pp 755-764, issn 0007-1188, 10 p.Article

Drug efficact and drug resistance : Drug efficact and drug resistanceFARDEL, Olivier; JIGOREL, Emilie; LE VEE, Marc et al.Biomedicine & pharmacotherapy. 2005, Vol 59, Num 3, pp 104-114, issn 0753-3322, 11 p.Article

Theoretical context-sensitive elimination times for inhalation anaestheticsLOCKWOOD, G.British journal of anaesthesia. 2010, Vol 104, Num 5, pp 648-655, issn 0007-0912, 8 p.Article

Pharmacokinetics of trefoil peptides and their stability in gastrointestinal contentsKJELLEU, Stine; VESTERGAARD, Else Marie; NEXØ, Ebba et al.Peptides (New York, NY. 1980). 2007, Vol 28, Num 6, pp 1197-1206, issn 0196-9781, 10 p.Article

The pharmacokinetic and pharmacodynamic properties of biphasic insulin aspart 70 (BIAsp 70) are significantly different from those of biphasic insulin aspart 30 (BIAasp 30)BOTT, S; TUSEK, C; HEINEMANN, L et al.Experimental and clinical endocrinology & diabetes. 2005, Vol 113, Num 9, pp 545-550, issn 0947-7349, 6 p.Article

Pharmacokinetics of ¹²⁵I-radiolabelled PEG-hemoglobin SB1LEE, Jiwon; LEE, Junhee; YOON, Sojung et al.Artificial cells, blood substitutes, and biotechnology. 2006, Vol 34, Num 3, pp 277-292, 16 p.Article

Factors affecting pharmacokinetics of monoclonal antibodies: A review articleIZNAGA-ESCOBAR, N; MISHRA, A. K; PEREZ-RODRIGUEZ, R et al.Methods and findings in experimental and clinical pharmacology. 2004, Vol 26, Num 2, pp 123-127, issn 0379-0355, 5 p.Article

Recent pharmacological advances in paediatric analgesics : Acute and chronic pain managementANDERSON, B. J; PALMER, G. M.Biomedicine & pharmacotherapy. 2006, Vol 60, Num 7, pp 303-309, issn 0753-3322, 7 p.Article

Enhancing the bioavailability of resveratrol by combining it with piperine : Resveratrol: Current Status and OutlookJOHNSON, Jeremy J; NIHAL, Minakshi; SIDDIQUI, Imtiaz A et al.Molecular nutrition & food research (Print). 2011, Vol 55, Num 8, pp 1169-1176, issn 1613-4125, 8 p.Article

The interaction of gallium with biological systemsHAYES, R. L.International journal of nuclear medicine & biology. 1983, Vol 10, Num 4, pp 257-261, issn 0047-0740Article

Population pharmacokinetic model of PI-88, a heparanase inhibitorHUDACHEK, Susan F; ECKHARDT, S. Gail; HICKS, Barbara et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 4, pp 743-753, issn 0344-5704, 11 p.Article

Some considerations on the design of population pharmacokinetic studiesDUFFULL, Stephen; WATERHOUSE, Tim; ECCLESTON, John et al.Journal of pharmacokinetics and pharmacodynamics (Print). 2005, Vol 32, Num 3-4, pp 441-457, issn 1567-567X, 17 p.Article